237 related articles for article (PubMed ID: 22981800)
1. The effect of TLR4/7 on the TGF-β-induced Smad signal transduction pathway in human keloid.
Chen J; Zeng B; Yao H; Xu J
Burns; 2013 May; 39(3):465-72. PubMed ID: 22981800
[TBL] [Abstract][Full Text] [Related]
2. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
Wu CS; Wu PH; Fang AH; Lan CC
Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
[TBL] [Abstract][Full Text] [Related]
3. [Effects of interferon-gamma on the transforming growth factor beta/Smad pathway in keloid-derived fibroblasts].
Liu JQ; Hu DH; Zhang ZF; Guan H; She T; Zhang J; Bai XZ
Zhonghua Shao Shang Za Zhi; 2009 Dec; 25(6):454-9. PubMed ID: 20193171
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
He S; Liu X; Yang Y; Huang W; Xu S; Yang S; Zhang X; Roberts MS
Br J Dermatol; 2010 Mar; 162(3):538-46. PubMed ID: 19772524
[TBL] [Abstract][Full Text] [Related]
5. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
[TBL] [Abstract][Full Text] [Related]
6. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts.
Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J
Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513
[TBL] [Abstract][Full Text] [Related]
7. [Expression of Smads in keloid scarring].
Tang B; Zhu B; Bi LK; Xue CL; Cai H; Zhu JY
Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(12):941-3. PubMed ID: 19781253
[TBL] [Abstract][Full Text] [Related]
8. Increased Cthrc1 Activates Normal Fibroblasts and Suppresses Keloid Fibroblasts by Inhibiting TGF-β/Smad Signal Pathway and Modulating YAP Subcellular Location.
Zhao MJ; Chen SY; Qu XY; Abdul-Fattah B; Lai T; Xie M; Wu SD; Zhou YW; Huang CZ
Curr Med Sci; 2018 Oct; 38(5):894-902. PubMed ID: 30341526
[TBL] [Abstract][Full Text] [Related]
9. TGF-ß1 antisense impacts the SMAD signalling system in fibroblasts from keloid scars.
Bran GM; Sommer UJ; Goessler UR; Hörmann K; Riedel F; Sadick H
Anticancer Res; 2010 Sep; 30(9):3459-63. PubMed ID: 20944123
[TBL] [Abstract][Full Text] [Related]
10. Keloid fibroblasts are more sensitive to Wnt3a treatment in terms of elevated cellular growth and fibronectin expression.
Chua AW; Gan SU; Ting Y; Fu Z; Lim CK; Song C; Sabapathy K; Phan TT
J Dermatol Sci; 2011 Dec; 64(3):199-209. PubMed ID: 22005028
[TBL] [Abstract][Full Text] [Related]
11. Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions.
Tsujita-Kyutoku M; Uehara N; Matsuoka Y; Kyutoku S; Ogawa Y; Tsubura A
In Vivo; 2005; 19(6):959-63. PubMed ID: 16277007
[TBL] [Abstract][Full Text] [Related]
12. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
[TBL] [Abstract][Full Text] [Related]
14. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of FOXM1 inhibits activation of keloid fibroblasts and extracellular matrix production via inhibition of TGF-β1/Smad pathway.
Zhang Y; Cheng C; Wang S; Xu M; Zhang D; Zeng W
Life Sci; 2019 Sep; 232():116637. PubMed ID: 31288014
[TBL] [Abstract][Full Text] [Related]
16. Oxymatrine inhibits collagen synthesis in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
Fan DL; Zhao WJ; Wang YX; Han SY; Guo S
Int J Dermatol; 2012 Apr; 51(4):463-72. PubMed ID: 22435440
[TBL] [Abstract][Full Text] [Related]
17. Suppression of TGF-β1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid.
Hsu YC; Chen MJ; Yu YM; Ko SY; Chang CC
Arch Dermatol Res; 2010 Dec; 302(10):717-24. PubMed ID: 20717830
[TBL] [Abstract][Full Text] [Related]
18. [Effects of blocking two sites of transforming growth factor-β/Smads signaling on the formation of scar-related proteins in human skin fibroblasts].
Wang Y; Zhang L; Lei R; Shen Y; Shen H; Wu Z; Xu J
Zhonghua Shao Shang Za Zhi; 2015 Oct; 31(5):372-7. PubMed ID: 26714407
[TBL] [Abstract][Full Text] [Related]
19. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
20. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW
Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
